UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM 8-K
CURRENT REPORT
Pursuant to Section
13 or 15(d) of
the Securities
Exchange Act of 1934
Date of Report (Date
of earliest event reported):
May
1, 2020 (April 29, 2020)
(Exact name of registrant
as specified in its charter)
Delaware
(State or other
jurisdiction of incorporation)
001-02217
(Commission
File Number)
58-0628465
(IRS Employer
Identification No.)
One Coca-Cola Plaza
Atlanta, Georgia
(Address of principal executive offices)
30313
(Zip Code)
Registrant's telephone
number, including area code: (404) 676-2121
Not Applicable
(Former name or former
address, if changed since last report)
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered
pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, $0.25 Par Value
KO
New York Stock Exchange
0.000% Notes Due 2021
KO21B
New York Stock Exchange
Floating Rate Notes Due 2021
KO21C
New York Stock Exchange
1.125% Notes Due 2022
KO22
New York Stock Exchange
0.125% Notes Due 2022
KO22B
New York Stock Exchange
0.75% Notes Due 2023
KO23B
New York Stock Exchange
0.500% Notes Due 2024
KO24
New York Stock Exchange
1.875% Notes Due 2026
KO26
New York Stock Exchange
0.750% Notes Due 2026
KO26C
New York Stock Exchange
1.125% Notes Due 2027
KO27
New York Stock Exchange
1.250% Notes Due 2031
KO31
New York Stock Exchange
1.625% Notes Due 2035
KO35
New York Stock Exchange
1.100% Notes Due 2036
KO36
New York Stock Exchange
Indicate by check mark
whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 ( 230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ( 240.12b-2 of this chapter).
Emerging
growth company
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act
Item 8.01Other Events.
On April 29, 2020, The Coca-Cola Company
(the Company ) completed a public offering of $1,500,000,000 aggregate principal amount of its 1.450% Notes due 2027,
$1,500,000,000 aggregate principal amount of its 1.650% Notes due 2030, $1,000,000,000 aggregate principal amount of its 2.500%
Notes due 2040, $1,500,000,000 aggregate principal amount of its 2.600% Notes due 2050 and $1,000,000,000 aggregate principal amount
of its 2.750% Notes due 2060 (collectively, the Notes ).
The offering of the Notes was made pursuant
to the Company s shelf registration statement on Form S-3 (Registration No. 333-234311) filed with the Securities and Exchange
Commission (the SEC ) on October 24, 2019.
In connection with the offering of the Notes,
the Company entered into an Underwriting Agreement, dated April 29, 2020 (the Underwriting Agreement ), among the
Company and Barclays Capital Inc., BNP Paribas Securities Corp., Deutsche Bank Securities Inc., HSBC Securities (USA) Inc., Morgan
Stanley Co. LLC and Santander Investment Securities Inc., as representatives of the several underwriters named therein (together,
the Underwriters ). Pursuant to the Underwriting Agreement, the Company agreed to sell the Notes to the Underwriters,
and the Underwriters agreed to purchase the Notes for resale to the public. The Underwriting Agreement includes customary representations,
warranties and covenants by the Company. It also provides for customary indemnification by each of the Company and the Underwriters
against certain liabilities and customary contribution provisions in respect of those liabilities.
The Notes were issued under an Amended and
Restated Indenture, dated as of April 26, 1988 (as supplemented, the Indenture ), between the Company and Deutsche
Bank Trust Company Americas, as successor to Bankers Trust Company, as trustee, as supplemented by the First Supplemental Indenture,
dated as of February 24, 1992, and the Second Supplemental Indenture, dated as of November 1, 2007, between the Company and Deutsche
Bank Trust Company Americas, as successor to Bankers Trust Company, as trustee.
The Underwriting Agreement, the Indenture
and the respective forms of global note for the offering are filed as exhibits to this Current Report on Form 8-K and are incorporated
herein by reference.
Item 9.01Financial Statements and Exhibits.
(d) Exhibits
In reviewing the agreements included as
exhibits to this report, please remember they are included to provide you with information regarding their terms and are not intended
to provide any other factual or disclosure information about the Company or the other parties to the agreements. The agreements
contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties
have been made solely for the benefit of the other parties to the applicable agreement and:
should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one
of the parties if those statements prove to be inaccurate;
may have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable
agreement, which disclosures are not necessarily reflected in the agreement;
may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors;
and
were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement
and are subject to more recent developments.
Accordingly, these representations and
warranties may not describe the actual state of affairs as of the date they were made or at any other time. Additional information
about the Company may be found elsewhere in this report and the Company s other public filings, which are available without
charge through the SEC s website at http://www.sec.gov.
Exhibit 1.1
Underwriting Agreement, dated April 29, 2020, between the Company and Barclays Capital Inc., BNP Paribas Securities Corp., Deutsche Bank Securities Inc., HSBC Securities (USA) Inc., Morgan Stanley Co. LLC and Santander Investment Securities Inc., as representatives of the several underwriters named therein.
Exhibit 4.1
Amended and Restated Indenture, dated as of April 26, 1988, between the Company and Deutsche Bank Trust Company Americas, as successor to Bankers Trust Company, as trustee.
Exhibit 4.2
First Supplemental Indenture, dated as of February 24, 1992, to Amended and Restated Indenture, dated as of April 26, 1988, between the Company and Deutsche Bank Trust Company Americas, as successor to Bankers Trust Company, as trustee.
Exhibit 4.3
Second Supplemental Indenture, dated as of November 1, 2007, to Amended and Restated Indenture, dated as of April 26, 1988, as amended, between the Company and Deutsche Bank Trust Company Americas, as successor to Bankers Trust Company, as trustee.
Exhibit 4.4
Form of Note for 1.450% Notes due 2027.
Exhibit 4.5
Form of Note for 1.650% Notes due 2030.
Exhibit 4.6
Form of Note for 2.500% Notes due 2040.
Exhibit 4.7
Form of Note for 2.600% Notes due 2050.
Exhibit 4.8
Form of Note for 2.750% Notes due 2060.
Exhibit 5.1
Opinion of Skadden, Arps, Slate, Meagher Flom LLP.
Exhibit 23.1
Consent of Skadden, Arps, Slate, Meagher Flom LLP included as part of Exhibit 5.1 hereto.
Exhibit 104
Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.